Castor vs Medable(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Castor

Best for
Biotech, device and academic teams that want eCOA, eConsent and EDC in one platform with a self-service option
What to consider
Castor offers a validated instrument library with licensing handled by its services team, self-service builds that go live in weeks and a published pricing process with an entry package for early-stage companies. Its global reach and regulatory track record are smaller than the enterprise platforms'.
Read product profile

Medable

Best for
Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform
What to consider
Medable pairs a large library (400+ validated instruments, 120+ locales) with Study Studio, a no-code builder its site says takes studies live in 4 to 6 weeks. It publishes Part 11, Annex 11, HIPAA and GDPR compliance but no regulatory approval counts or prices.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Castor vs Medable (eCOA): category feature evidence and sources. Products are not ranked.
Category featureCastorMedable
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Extended support

Library of validated instruments (EORTC, FACT-G, EQ-5D, SF-36, PROMIS); Professional Services manages scale licensing and validation; library size not published.

Source
About this support label

Validated instruments are available, with licensing and validation managed by Professional Services.

Supported

400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked.

Source
About this support label

A validated library is documented; licensing services are not described.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

Fully validated, 21 CFR Part 11 and GxP compliant platform used in 6,100+ trials; no regulatory approval counts published.

Source
About this support label

Part 11 and GxP compliance are stated; approval counts are not published.

Supported

States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published.

Source
Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Supported

80+ languages through translation services, 10+ pre-translated interface languages and 24/7 support.

Source
About this support label

Language support is documented; this note does not establish multicountry use.

Extended support

80+ countries and 120+ locales; device logistics from six global depots to 65+ countries.

Source
About this support label

The note documents deployment across countries and localized participant support.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Supported

BYOD app, browser, SMS and messaging apps, site tablet mode and provisioned devices; integrates with major EDCs via REST API and webhooks. Wearable or sensor capture not documented.

Source
About this support label

App, web and EDC connections are documented; wearable or sensor capture is not.

Extended support

eCOA, eConsent, TeleVisit and devices in one platform, BYOD or provisioned, with sensors and connectors to other clinical systems.

Source
About this support label

BYOD and provisioned devices are documented alongside sensors and clinical-system connectors.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Extended support

Self-service and low-complexity eCOA builds go live in weeks; managed builds reach UAT in 4 to 8 weeks.

Source
About this support label

Self-service builds go live in weeks; managed builds reach UAT in four to eight weeks.

Supported

Study Studio is a no-code visual builder; studies that took 16 to 20 weeks go live in 4 to 6 weeks, some in a day.

Source
About this support label

A no-code builder and launch timing are documented; study-team self-service is not explicit.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Supported

Pricing process published: itemized, fixed-scope proposal with change-control terms within 5 business days, plus a Castor Essentials package for early-stage companies; no prices.

Source
Supported

Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount.

Source
About this support label

A monthly device-provisioning model is described; platform prices are not published.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.